Tianjin Medical Journal ›› 2023, Vol. 51 ›› Issue (10): 1065-1070.doi: 10.11958/20230338
• Experimental Research • Previous Articles Next Articles
LIU Chang(), FAN Caihong, LIU Jia, LIU Yashan, ZHANG Shiqi, LIU Shiming, SHEN Yanna△(
)
Received:
2023-03-15
Revised:
2023-06-30
Published:
2023-10-15
Online:
2023-10-18
Contact:
∆E-mail:shenyanna@tmu.edu.cn
LIU Chang, FAN Caihong, LIU Jia, LIU Yashan, ZHANG Shiqi, LIU Shiming, SHEN Yanna. Naa20 alleviated myocardial injury in sepsis by inhibiting AIM2 expression[J]. Tianjin Medical Journal, 2023, 51(10): 1065-1070.
CLC Number:
基因 | 引物序列(5′→3′) | 产物大小/bp |
---|---|---|
Naa20 | 上游:GACGACCTGTTCCGCTTCAA 下游:TCTGCTTTGCCCATAACCAA | 148 |
GAPDH | 上游:CATGAGAAGTATGACAACAGCT 下游:AGTCCTTCCACGATACCAAAGT | 197 |
Tab.1 Primer sequences for qPCR
基因 | 引物序列(5′→3′) | 产物大小/bp |
---|---|---|
Naa20 | 上游:GACGACCTGTTCCGCTTCAA 下游:TCTGCTTTGCCCATAACCAA | 148 |
GAPDH | 上游:CATGAGAAGTATGACAACAGCT 下游:AGTCCTTCCACGATACCAAAGT | 197 |
组别 | LVEF | FS/% | CK-MB/(ng/L) |
---|---|---|---|
对照组 | 0.70±0.04 | 37.93±3.48 | 345.84±250.09 |
模型组 | 0.40±0.05 | 18.88±3.05 | 7 573.23±1 194.54 |
t | 10.765** | 10.084** | 14.506** |
Tab.2 Comparison of left ventricular ejection fraction, fraction shortening and CK-MB between two groups of mice
组别 | LVEF | FS/% | CK-MB/(ng/L) |
---|---|---|---|
对照组 | 0.70±0.04 | 37.93±3.48 | 345.84±250.09 |
模型组 | 0.40±0.05 | 18.88±3.05 | 7 573.23±1 194.54 |
t | 10.765** | 10.084** | 14.506** |
组别 | AIM2 | GSDMD | GSDMD-N | |||
---|---|---|---|---|---|---|
对照组 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | |||
LPS处理组 | 3.65±1.49 | 2.47±0.16 | 1.57±0.21 | |||
t | 3.103* | 15.777** | 4.637* | |||
组别 | IL-1β | p17 | IL-1β/(ng/L) | |||
对照组 | 1.00±0.00 | 1.00±0.00 | 1.07±0.35 | |||
LPS处理组 | 2.76±0.38 | 2.52±0.27 | 30.24±2.53 | |||
t | 7.958** | 9.782** | 19.759** |
Tab.3 Comparison of AIM2, GSDMD, IL-1β, p17 protein expression levels and IL-1β content in supernatant between two groups
组别 | AIM2 | GSDMD | GSDMD-N | |||
---|---|---|---|---|---|---|
对照组 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | |||
LPS处理组 | 3.65±1.49 | 2.47±0.16 | 1.57±0.21 | |||
t | 3.103* | 15.777** | 4.637* | |||
组别 | IL-1β | p17 | IL-1β/(ng/L) | |||
对照组 | 1.00±0.00 | 1.00±0.00 | 1.07±0.35 | |||
LPS处理组 | 2.76±0.38 | 2.52±0.27 | 30.24±2.53 | |||
t | 7.958** | 9.782** | 19.759** |
组别 | Naa20 mRNA | Naa20蛋白 |
---|---|---|
对照组 | 1.01±0.21 | 1.00±0.00 |
LPS 1 mg/L组 | 1.71±0.16a | 2.19±0.54a |
LPS 5 mg/L组 | 1.70±0.02a | 2.28±0.39a |
LPS 10 mg/L组 | 2.13±0.20a | 2.34±0.47a |
F | 23.662** | 7.296* |
Tab.4 Comparison of Naa20 levels between four groups of neonatal rat cardiomyocytes
组别 | Naa20 mRNA | Naa20蛋白 |
---|---|---|
对照组 | 1.01±0.21 | 1.00±0.00 |
LPS 1 mg/L组 | 1.71±0.16a | 2.19±0.54a |
LPS 5 mg/L组 | 1.70±0.02a | 2.28±0.39a |
LPS 10 mg/L组 | 2.13±0.20a | 2.34±0.47a |
F | 23.662** | 7.296* |
组别 | 细胞活力/% | LDH/(U/mg) |
---|---|---|
对照组 | 97.16±2.81 | 141.43±3.04 |
Naa20对照组 | 95.52±1.83 | 147.63±19.12 |
LPS组 | 46.99±3.96a | 254.22±14.92a |
Naa20+LPS组 | 74.44±3.15b | 182.20±5.94b |
F | 178.801** | 50.825** |
Tab.5 Comparison of H9c2 cell viability and LDH levels between four groups
组别 | 细胞活力/% | LDH/(U/mg) |
---|---|---|
对照组 | 97.16±2.81 | 141.43±3.04 |
Naa20对照组 | 95.52±1.83 | 147.63±19.12 |
LPS组 | 46.99±3.96a | 254.22±14.92a |
Naa20+LPS组 | 74.44±3.15b | 182.20±5.94b |
F | 178.801** | 50.825** |
组别 | Ac | AIM2 | GSDMD | GSDMD-N | IL-1β/(ng/L) |
---|---|---|---|---|---|
对照组 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 1.07±0.30 |
Naa20对照组 | 0.97±0.27 | 0.92±0.23 | 0.96±0.24 | 1.12±0.20 | 1.07±0.18 |
LPS组 | 8.01±1.55a | 2.43±0.39a | 3.35±0.97a | 3.94±0.88a | 28.06±2.18a |
Naa20+LPS组 | 14.98±4.49b | 1.21±0.38b | 1.43±0.52b | 1.44±0.36b | 16.48±4.00b |
F | 23.841** | 16.919** | 12.134* | 24.692** | 98.943** |
Tab.6 Comparison of ace-AIM2 and AIM2, GSDMD, GSDMD-N protein, and IL-1β content in supernatant between four groups of H9c2 cells
组别 | Ac | AIM2 | GSDMD | GSDMD-N | IL-1β/(ng/L) |
---|---|---|---|---|---|
对照组 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 1.07±0.30 |
Naa20对照组 | 0.97±0.27 | 0.92±0.23 | 0.96±0.24 | 1.12±0.20 | 1.07±0.18 |
LPS组 | 8.01±1.55a | 2.43±0.39a | 3.35±0.97a | 3.94±0.88a | 28.06±2.18a |
Naa20+LPS组 | 14.98±4.49b | 1.21±0.38b | 1.43±0.52b | 1.44±0.36b | 16.48±4.00b |
F | 23.841** | 16.919** | 12.134* | 24.692** | 98.943** |
[1] | VAN DER POLL T, VAN DE VEERDONK F L, SCICLUNA B P, et al. The immunopathology of sepsis and potential therapeutic targets[J]. Nat Rev Immunol, 2017, 17(7):407-420. doi:10.1038/nri.2017.36. |
[2] | PRESCOTT H C, ANGUS D C. Post sepsis morbidity[J]. JAMA, 2018, 319(1):91. doi:10.1001/jama.2017.19809. |
[3] | ZYCHLINSKY A, PREVOST M C, SANSONETTI P J. Shigella flexneri induces apoptosis in infected macrophages[J]. Nature, 1992, 358(6382):167-169. doi:10.1038/358167a0. |
[4] | WANG B, TIAN Y, YIN Q. AIM2 inflammasome assembly and signaling[J]. Adv Exp Med Biol, 2019, 1172:143-155. doi:10.1007/978-981-13-9367-9_7. |
[5] | DRAZIC A, MYKLEBUST L M, REE R, et al. The world of protein acetylation[J]. Biochim Biophys Acta, 2016, 1864(10):1372-1401. doi:10.1016/j.bbapap.2016.06.007. |
[6] | REE R, VARLAND S, ARNESEN T. Spotlight on protein N-terminal acetylation[J]. Exp Mol Med, 2018, 50(7):1-13. doi:10.1038/s12276-018-0116-z. |
[7] | AKSNES H, REE R, ARNESEN T. Co-translational,post-translational,and non-catalytic roles of n-terminal acetyltransferases[J]. Mol Cell, 2019, 73(6):1097-1114. doi:10.1016/j.molcel.2019.02.007. |
[8] | JUNG T Y, RYU J E, JANG M M, et al. Naa20,the catalytic subunit of NatB complex,contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis[J]. Exp Mol Med, 2020, 52(11):1831-1844. doi:10.1038/s12276-020-00525-3. |
[9] | OISHI K, YAMAYOSHI S, KOZUKA-HATA H, et al. N-terminal acetylation by NatB is required for the shutoff activity of influenza A virus PA-X[J]. Cell Rep, 2018, 24(4):851-860. doi:10.1016/j.celrep.2018.06.078. |
[10] | LIU C, ZOU Q, TANG H, et al. Melanin nanoparticles alleviate sepsis-induced myocardial injury by suppressing ferroptosis and inflammation[J]. Bioact Mater, 2023, 24:313-321. doi:10.1016/j.bioactmat.2022.12.026. |
[11] | EHRMAN R R, SULLIVAN A N, FAVOT M J, et al. Pathophysiology,echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy:a review of the literature[J]. Crit Care, 2018, 22(1):112. doi:10.1186/s13054-018-2043-8. |
[12] | STORGAARD M, HALLAS J, GAHRN-HANSEN B, et al. Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock[J]. Scand J Infect Dis, 2013, 45(8): 577-583. doi:10.3109/00365548.2013.786836. |
[13] | LIU Y C, YU M M, SHOU S T, et al. Sepsis-induced cardiomyopathy:mechanisms and treatments[J]. Front Immunol, 2017, 8: 1021. doi:10.3389/fimmu.2017.01021. |
[14] | SANTOS L C, VOGEL R, CHIPUK J E, et al. Mitochondrial origins of fractional control in regulated cell death[J]. Nat Commun, 2019, 10(1):1313. doi:10.1038/s41467-019-09275-x. |
[15] | SUN Y, YAO X, ZHANG Q J, et al. Beclin-1-dependent autophagy protects the heart during sepsis[J]. Circulation, 2018, 138(20):2247-2262. doi:10.1161/CIRCULATIONAHA. |
[16] | LI N, ZHOU H, WU H, et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction,inflammation,apoptosis and pyroptosis by activating NLRP3[J]. Redox Biol, 2019, 24:101215. doi:10.1016/j.redox.2019.101215. |
[17] | 靳文, 刘云峰, 劳钰, 等. 黑色素瘤缺乏因子2炎性小体在心肌梗死后心肌纤维化中的作用[J]. 实用医学杂志, 2019, 35(13):2035-2039. |
JIN W, LIU Y F, LAO Y, et al. The role of the absent in melanoma 2 inflammasome in myocardial fibrosis after myocardial infarction[J]. The Journal of Practical Medicine, 2019, 35(13):2035-2039. doi:10.3969/j.issn.1006-5725.2019.13.002. | |
[18] | WANG X, PAN J, LIU H, et al. AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model[J]. Life Sci, 2019, 221:249-258. doi:10.1016/j.lfs.2019.02.035. |
[19] | LI Y, XING N, YUAN J, et al. Sevoflurane attenuates cardiomyocyte apoptosis by mediating the miR-219a/AIM2/TLR4/MyD88 axis in myocardial ischemia/reperfusion injury in mice[J]. Cell Cycle, 2020, 19(13):1665-1676. doi:10.1080/15384101.2020.1765512. |
[20] | VENKATACHALAM K, PRABHU S D, REDDY V S, et al. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury[J]. J Biol Chem, 2009, 284(12):7853-7865. doi:10.1074/jbc.M808824200. |
[21] | MORRISON J, ALTUWAIJRI N K, BRONSTAD K, et al. Missense NAA20 variants impairing the NatB protein N-terminal acetyltransferase cause autosomal recessive developmental delay,intellectual disability, and microcephaly[J]. Genet Med, 2021, 23(11):2213-2218. doi:10.1038/s41436-021-01264-0. |
[22] | VAN DAMME P, LASA M, POLEVODA B, et al. N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB[J]. Proc Natl Acad Sci U S A, 2012, 109(31):12449-12454. doi:10.1073/pnas.1210303109. |
[1] | CHU Jiyan, TIAN Jing, FU Diyu, GUO Lin, SUN Rui, LI Ping. Expression and significance of AIM2 inflammasome in patients with acute gouty arthritis [J]. Tianjin Medical Journal, 2024, 52(5): 518-522. |
[2] | WANG Yue, QUAN Xingmiao, WANG Yu, SONG Chunxia, SHAO Yue, XU Liwei. Influence of Yiqi Shengqing recipe on neuron pyroptosis in ischemic stroke rats by regulating HIF-1α/NLRP3 signal pathway [J]. Tianjin Medical Journal, 2024, 52(4): 350-355. |
[3] | XIANG Jinjie, LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao. Molecular mechanisms of Ca2+-induced pyroptosis and adhesion changes of HK-2 cells in the formation of calcium-containing kidney stones [J]. Tianjin Medical Journal, 2024, 52(3): 250-255. |
[4] | GAO Guangren, FENG Lianrong, FU Jinguo, GUO Run, NIU Heping, LI Fengpeng, ZHANG Qianyu, ZHANG Jun. Characteristics of myocardial injury in patients with acute myocardial infarction complicated with pleural effusion and its influence on long-term prognosis [J]. Tianjin Medical Journal, 2024, 52(2): 197-200. |
[5] | LIU Guoqi, LI Chengcheng, LIU Shengju, ZHU Liying. Emodin regulates histone acetylation to promote pyroptosis and apoptosis of HpG2 hepatoma cells [J]. Tianjin Medical Journal, 2024, 52(1): 56-60. |
[6] | WANG Xiaohong, QIAN Jing, WANG Jiawei, QI Xiaoming, MENG Yun, WANG Ping, CHENG Ruizhi, ZHOU Guoxiong. The study on the mechanism of salidroside in the adjuvant treatment of patients with moderately severe acute pancreatitis [J]. Tianjin Medical Journal, 2023, 51(7): 762-765. |
[7] | SUN Liyan, LIU Zeru, SU Yongsheng, AI Hongliang. Effect of asperuloside on pyroptosis of lung tissue in septic rats by regulating NLRP3/Caspase-1/GSDMD signaling pathway [J]. Tianjin Medical Journal, 2023, 51(6): 607-612. |
[8] | PAN Ting, LI Zuoxiao, WAN Li. Study on the effect and mechanism of paclitaxel on pyroptosis in mice with experimental autoimmune encephalomyelitis [J]. Tianjin Medical Journal, 2023, 51(3): 259-262. |
[9] | HU Yingshan, WANG Jingjing, GAO Hongmei. Research progress in the pathogenesis of sepsis-related intestinal dysfunction [J]. Tianjin Medical Journal, 2023, 51(3): 333-336. |
[10] | LI Juan, YUAN Xiang-fei, ZHAO Yu. Relationship between NLRP3 and inflammatory molecules expression in intestinal mucosa cells of mice with FPIES [J]. Tianjin Medical Journal, 2021, 49(8): 829-832. |
[11] | LIU Yu, , WANG Zhao-yang, LI Shi-peng, HU Sha-sha, , YANG Shuang, CAI Jin-zhen, ZHANG Guo-liang△ . Interferon regulatory factor-1 participates in hepatic ischemia reperfusion injury in mice by regulating pyroptosis [J]. Tianjin Medical Journal, 2021, 49(5): 465-471. |
[12] | MIAO Jia-ning, CONG Yan-fei, LI Fang, LOU Yi, WANG Li-li. The role of P2RX7 and histone modification in trichostatin A alleviating mouse ovary injury induced by cigarette smoke exposure [J]. Tianjin Medical Journal, 2021, 49(10): 1053-1057. |
[13] | LIU Hai-ying, FENG Zi-ren, SUN Hui, MENG Ai-guo, ZHAO Jun-jian, ZHANG Wen-ting. The relationship between PPAR gamma activation and pyroptosis in the early stage of cerebral ischemia-reperfusion in rats [J]. Tianjin Medical Journal, 2020, 48(1): 34-37. |
[14] | WANG Xing-xing1,SONG Hu1,DU Chen-yang1,WANG Zhen2,ZHANG Jian-jun2△. Recent research progress of pyroptosis [J]. Tianjin Med J, 2018, 46(11): 1252-1256. |
[15] | DU Chen-yang, SONG Hu, WANG Xing-xing, WANG Zhen, ZHANG Jian-jun. miR-182-5p regulates pyroptosis involving liver ischemia reperfusion injury [J]. Tianjin Medical Journal, 2018, 46(10): 1045-1050. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||